2024-12-22-世界卫生组织-Guideline_Development_Group_for_clinical_management_and_diagnosis_of_dengue,_chikungunya,_Zika_and_yellow_fever_22页_377kb

World Health Organization Guideline Development Group (GDG) for Dengue, Chikungunya, Zika, and Yellow Fever Management

1. Introduction

• This document summarizes the members of the WHO Guideline Development Group (GDG) formed to develop clinical management and diagnosis guidelines for Dengue, Chikungunya, Zika, and Yellow Fever.
• The GDG comprised a diverse team spanning multiple countries in Africa, Asia, and the Americas.
• All members declared potential conflicts of interest, with exceptions noted where action was deemed unnecessary.

2. GDG Members

Below is a summary of the Key Information and Contributions of the Member Experts:

Name	Key Affiliation/Position	Specialties/Focus Areas
Taj-Eldin M. Abdallah	Sudan - Internal Medicine, Arboviral Expert	Infectious Diseases teaching, clinical practice, arboviral infections research.
Ashutosh Biswas	India - Infectious Diseases, Virology	Vector-borne diseases, guideline development, public health training, clinical investigations.
Orlando Cuéllar	Bolivia - Transfusion Service CMO	Hematology, Transfusion Medicine, Quality Management, Arbovirus, Dengue Management.
Ismaël Diallo	Burkina Faso - Infectious Diseases	Infectious Diseases training, clinical practice, Arboviral Training (VIP).
Cristina Domingo Carrasco	Germany - Robert Koch Institute	Virology, Public Health collaborations, Laboratory capacities, Arbovirus Outbreak response.
Pillaveetil S. Indu	India - Community Medicine	Epidemiology, HIV/Vaccine advisory, Dengue control, guideline development, Surveillance.
Emilie Javelle	France - Military/French Armed Forces	Military field medicine, Tropical diseases surveillance, Paediatrics, Arbovirus Training.
Mikaïla Kaboré	Burkina Faso - Infectious Diseases (adult HIV)	Emerging epidemic response, Training, clinical management (incl. Dengue, COVID-19).
Marta Lado	UK - Global Health Expert (Sierra Leone based)	Viral Haemorrhagic Fevers, Case Management (Ebola, Lassa, COVID-19 response).
Yee-Sin Leo	Singapore - Infectious Disease Specialist	Arboviruses (Dengue, ZIka, Chikungunya), HIV, Tropical Medicine, WHO role.
Lucy Chai See Lum	Singapore - Paediatric Intensive Care/Dengue	Dengue guideline revisions, clinical management, especially in resource-limited settings.
Pisake Lumbiganon	Thailand - Obstetrics & Gynaecology Professor	Systematic reviews, Reproductive Health research, Arbovirus technical consultant (WHO).
Kleber G. Luz	Brazil - Professor & International Consultant	Arboviruses (WHO/PAHO), Infectious diseases, Tropical medicine.
Carlos Pardo-Villamizar	USA - Professor of Neurology/Neuropathology	Neuro-infections, Myelitis, Neuroimmunology.
Mostafa Salehi-Vaziri	Iran - Medical Virologist/Aro Virus Expert	Emerging/remerging Arboviruses (DENV, CHIKV, YFV), Diagnostics, COVID-19 Vaccine surveillance.
Erin Staples	USA - Medical Epidemiologist (CDC)	Arboviral surveillance, Clinical care/testing prevention guidance, Diagnostics.
Michel Van Herp	Belgium - Epidemiologist	Major epidemics, MSF clinical epidemiology, Yellow Fever outbreak coordination/IWG.
Maria E. Villanueva-Uy	Philippines - Neonatologist/Paediatrician	Neonatal research, Neurodevelopment, Paediatric infections, Dengue outcomes/studies.
Liya Wassie	Ethiopia - Immunology Researcher (TB focus)	Tuberculosis biomarkers/translational research, National Immunization Technical Advisory Committee (NITAG).

3. Declaration of Interests

• Conflicts of interest were declared by all members.
• Professor Lum received research support from Sysmex Asia-Pacific.
• Doctor Staples holds employment as an expert for US CDC on arboviruses.
• Dr. Wassie's employer received research funding related to acute febrile illnesses.
• Explicit decisions were made that actions were "no action needed" regarding declared conflicts for Staples and Wassie, although specifics were not provided in the summary. No conflicts were identified for the majority of other members.